Put the phone face-down.
Lock in.
A performance nutraceutical capsule engineered for sustained attention under deadline pressure. Zero hidden fillers. Transparent clinical dosing.
"The work is waiting. Lock in."
Twenty tabs open. Three group chats buzzing. One deadline that does not move. You don't need more energy. You need the noise to fade, so you can lock in.
The scattered mind is an engineered problem.
Context Switching
Slack pings, WhatsApp threads, 20 open browser tabs. Research shows it takes over 20 minutes to regain deep focus after a single interruption.
Spikes & Crashes
Pouring another espresso temporarily suppresses adenosine, but delivers jitter, elevated heart rate, and an inevitable afternoon crash.
Hidden Doses
Generic supplement brands pack 20+ ingredients into a single capsule with micro-doses that look impressive on Amazon but do nothing in practice.
What locking in actually looks like.
Calm Intensity
Not frantic energy or restless pacing. Locking in is quiet, decisive momentum where the noise fades out and the single task in front of you becomes clear.
Sustained Output
Focus that lasts through the difficult middle of a project—without jitters, elevated anxiety, or an uncomfortable crash at 5 PM.
Coming at launch: full formula and batch reports.
Zero Proprietary Blends
No hiding sub-therapeutic doses behind a vague "focus matrix." Every single active compound and exact milligram count will be published in plain sight.
Third-Party Lab Reports
Every commercial batch links directly to an independent, accredited laboratory Certificate of Analysis verifying purity, active potency, and heavy metals.
Clinical Trial Dosing
If a compound requires 200mg in peer-reviewed human trials to produce an effect, it gets 200mg—or it does not enter the capsule.
Built in the open.
Last updated September 2026.
- Company incorporated September 2026
- Formula in final review Four actives + B-complex blend
- GST registration In process
- Manufacturing partner Being finalised
- Third-party lab report Comes with batch 1
- On sale Nothing is shipping yet
Why we are building LockIn.
Most supplement brands in India operate on the same playbook: buy a stock kitchen-sink formula with 25 ingredients, dose each at a fraction of what clinical literature requires so they can put it on the label, and hide the rest behind a "proprietary blend."
We built LockIn because we live the same reality you do. 14-hour days, context-switching between tabs, high-stakes deliverables, and the mental fatigue of trying to maintain deep focus when fatigue sets in. Coffee gives you jitters and a 3 PM crash. Energy drinks load you with sugar.
LockIn is our answer: a clean, clinically dosed nootropic capsule built specifically for the way Indian professionals and students actually perform. When we launch, every milligram of every compound is published, backed by human trial citations, and verified by batch-level third-party lab reports.
No investor exaggeration, no pseudo-scientific buzzwords, and no social media gimmicks. Just honest, uncompromising cognitive support.
Ishan Vasisth
Co-Founder
IIT BombayPrateek Behera
Co-Founder
Edtech & SystemsDirect Inquiry
contact@lockinpill.comCommon inquiries.
LockIn is a performance nutraceutical capsule engineered for cognitive focus and attention. It is formulated in a size 00 vegetarian (HPMC) capsule designed for Indian working professionals and students facing intense mental demands.
We are currently finalising the first 10,000-capsule pilot batch with our manufacturing partner. While we do not reveal the exact proprietary extraction ratios prior to launch, we have a standing commitment: at launch, every single compound, milligram dose, and third-party lab Certificate of Analysis will be published in full.
We do not promise artificial launch dates until quality testing is 100% verified. Joining the waitlist guarantees priority access and early-supporter pricing for the first 200 pilot allocations.
No. LockIn is categorized as a Nutraceutical under FSSAI regulations. It is not intended to treat, cure, or diagnose any medical or psychiatric condition.
Get notified the moment batch #01 clears testing.
No marketing spam. You will receive the formula disclosure, Certificate of Analysis, and early access link before general release.